Mentol, Noriven G.

HRN: 26-98-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
CEFTRIAXONE 1G (VIAL)
05/03/2025
05/09/2025
IV
2g
OD
CAP MR
Waiting Final Action 
05/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/09/2025
05/23/2025
IV
500mg
Q8H
Cholecystitis
Waiting Final Action 
05/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/14/2025
05/20/2025
IV
4.5g
Q8
CAP-MR
Rejected 
05/22/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/22/2025
05/29/2025
IV
4.5g
Q8
S/p Ex Lap Appendectomy And Lavage And Right Salpingo Oophorectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: